Advanced Biomed Inc Disposal Group, Including Discontinued Operation, General and Administrative Expense
Advanced Biomed Inc (ADVB) reported Disposal Group, Including Discontinued Operation, General and Administrative Expense of $272.87 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense · last filed 2026-05-15
- Advanced Biomed Inc disposal group, including discontinued operation, general and administrative expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Advanced Biomed Inc disposal group, including discontinued operation, general and administrative expense for the quarter ending 2025-12-31 was $144.24K, a 32.81% decline year-over-year.
- Advanced Biomed Inc disposal group, including discontinued operation, general and administrative expense for the quarter ending 2025-03-31 was $164.74K.
- Advanced Biomed Inc disposal group, including discontinued operation, general and administrative expense for the quarter ending 2024-12-31 was $214.68K.
| Period end | Disposal Group, Including Discontinued Operation, General and Administrative Expense 3 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 6 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 9 month |
|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $144.24K derived: sum of 2 quarters · filed 2026-05-15 | $272.87K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $144.24K 10-Q · filed 2026-02-13 | $272.87K 10-Q · filed 2026-02-13 | |
| 2025-03-31 | $164.74K 10-Q · filed 2026-05-15 | $379.42K derived: sum of 2 quarters · filed 2026-05-15 | $657.86K 10-Q · filed 2026-05-15 |
| 2024-12-31 | $214.68K 10-Q · filed 2026-02-13 | $493.12K 10-Q · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |